Understanding the
interplay between

cancer, patient & therapy

Understanding the
interplay between

cancer, patient
and therapy

An integrated approach
to precision oncology

An integrated approach to
precision oncology

An integrated approach
to precision oncology

An integrated approach to
precision oncology

OncoHost is advancing a new paradigm in precision oncology.
The PROphet® platform supports clinical decision making by identifying plasma proteomic
patterns associated with resistance to therapy, predicting response to treatment,
and enabling earlier biology-driven interventions to optimize clinical outcomes.

A new dimension for personalization

Plasma Proteomic Profiling

Analyzing the biological interplay of the patient, tumor, and therapy can:
Enable early prediction
of individual response
to immunotherapy
Identify relevant therapeutic
strategies that may overcome
potential resistance to therapy

A new approach for
managing therapeutic strategies

Blood-based test
Not exclusive for
mutation carriers
Response
probability report
Next-line treatment
options stratification
Combination
therapy analysis

Contact us

USA office

1110 SE Cary Parkway, Suite 205
Cary, North Carolina 27518
T. (855) 950-2112
E. support@oncohost-us.com

Israel office

P.O.Box 446, 3 Hamelacha, Binyamina, Israel
T. +972 485 37558
E. info@oncohost.com